Evidence map›Paper›PMID 38953340›Full record

ArticleFuture cardiology2024

The influence of P2Y

Kornel Pawlak, Dorota Danielak, Paweł Burchardt, Łukasz Kruszyna, Marta Karaźniewicz-Łada

Abstract read
In one paragraph

Article in Future cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kornel PawlakDepartment of Physical Pharmacy & Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, Poznań 60-806, Poland.ORCID 0000-0002-8085-6276
Dorota DanielakDepartment of Physical Pharmacy & Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, Poznań 60-806, Poland.ORCID 0000-0001-5807-1109
Paweł BurchardtDepartment of Cardiology, Cardiovascular Unit, J. Strus Hospital, Poznan 61-285, Poland.ORCID 0000-0003-0353-3470
Łukasz KruszynaDepartment of Vascular & Endovascular Surgery, Angiology & Phlebology, Poznan University of Medical Sciences, Długa St., Poznań 61-848, Poland.ORCID 0000-0001-5205-5765
Marta Karaźniewicz-ŁadaDepartment of Physical Pharmacy & Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, Poznań 60-806, Poland.ORCID 0000-0003-4091-7035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ClopidogrelPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12AgedCoronary Artery DiseaseFemaleGenotypeHumansMaleMiddle AgedObesityPolymorphism, GeneticClopidogrelP2RY12 protein, humanPlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12antiplatelet therapyG52TPCR-RFLPplatelet activityrs6801273T744C

Identifiers

PMID38953340
PMCPMC11457605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.